This inventor holds 3 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 1997-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2002
Title: The Innovative Contributions of Daniel P. McNamara
Introduction
Daniel P. McNamara is a notable inventor based in Waterbury, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aerosol formulations. With a total of 3 patents to his name, McNamara's work has the potential to impact the way medications are delivered to patients.
Latest Patents
One of McNamara's latest patents is focused on pharmaceutical formulations for aerosols with two or more active substances. This invention relates to new pharmaceutical preparations for propellant-driven metered dose aerosols using a fluorohydrocarbon (HFC) as a propellant. The formulation contains a combination of active substances, with at least one being in dissolved form and another in the form of suspended particles. This innovation aims to enhance the efficacy of inhalation or nasal route administration.
Another significant patent by McNamara is a method and apparatus for homogenizing aerosol formulations. This method includes steps for homogenizing and micronizing aerosol formulations at ambient temperature within a closed apparatus maintained under elevated pressure. The apparatus features a closed loop that connects a reaction vessel, a homogenizer, and a fluid conduit. The homogenizer is equipped with an interaction chamber and an intensifier pump, which work together to optimize the aerosol formulation process.
Career Highlights
Daniel P. McNamara is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving aerosol delivery systems, which are crucial for effective medication administration.
Collaborations
Throughout his career, McNamara has collaborated with notable colleagues, including George A. DeStefano and Paul Donald Jager. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Daniel P. McNamara's contributions to pharmaceutical innovations, particularly in aerosol formulations, demonstrate his commitment to improving healthcare delivery. His patents reflect a deep understanding of the complexities involved in medication administration, and his work continues to influence the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
